The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Relationship between changes in left ventricular ejection and use of angiotensin-converting enzyme inhibitors and/or betablockers during adjuvant trastuzumab chemotherapy in early breast cancer: Data from the real world.
Francesco Giotta
No relevant relationships to disclose
Stefano Oliva
No relevant relationships to disclose
Lidia Boccardi
No relevant relationships to disclose
Silvia Frattini
No relevant relationships to disclose
Agnese Maria Fioretti
No relevant relationships to disclose
Edda Simoncini
No relevant relationships to disclose
Giovanni Pulignano
No relevant relationships to disclose
Gianni Cioffi
No relevant relationships to disclose
Chiara Lestuzzi
No relevant relationships to disclose
Nicola Maurea
No relevant relationships to disclose
Luigi Tarantini
No relevant relationships to disclose